Clinical trial
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
NCT00002608 · Ottawa Regional Cancer Centre, Other · Completed
Key facts
| NCT number | NCT00002608 |
|---|---|
| Title | Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors |
| Official title | Cisplatin, Doxorubicin and Tamoxifen in the Treatment of Incurable Soft Tissue and Endocrine Malignancies |
| Lead sponsor | Ottawa Regional Cancer Centre, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adrenocortical Carcinoma, Brain and Central Nervous System Tumors, Head and Neck Cancer, Liver Cancer, Malignant Mesothelioma, Pheochromocytoma, Sarcoma |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | cisplatin, doxorubicin hydrochloride, tamoxifen citrate, conventional surgery, radiation therapy |
| Enrollment | 30 |
| Start date | May 1, 1994 |
| Completion | Apr 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 10, 2013 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: